Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Docuply logo — The electronic quality management system with fully integrat...

Docuply

The electronic quality management system with fully integrated eTMF – for clinical biotech companies.

Founded 2022 Germany Mannheim, Germany 7 employees Seed Analytics, Biopharma +2

General Information

Company Name Docuply
Founded Year 2022
Location Germany Mannheim, Germany
Employees 7
Industries Analytics, Biopharma, Pharmaceutical +1
Funding Stage Seed
Business Model SaaS, B2B, Platform
Revenue Model Freemium, Subscription, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Docuply. To contact Docuply, visit docuply.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Docuply compare?

A PDF of Docuply and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Docuply soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Docuply

Docuply, founded in 2022, is an innovative startup headquartered in Germany that specializes in providing an electronic quality management system (eQMS) tailored specifically for small and medium enterprises (SMEs) and startups within the pharmaceutical sector. This SaaS platform addresses a crucial pain point by eliminating the stress associated with audits and inspections.

The company's offering is particularly attractive due to its pre-validated, ready-to-use nature, coupled with secure hosting within the EU cloud, ensuring compliance and ease of use. Positioned at the intersection of Analytics, Biopharma, and Pharmaceutical industries, Docuply has yet to receive any known investment, presenting a potentially lucrative opportunity for venture capitalists and early-stage investors.

In summary, Docuply's forward-thinking approach and strategic focus within the pharmaceutical industry make it a promising candidate for investment in the burgeoning regulatory technology sector.

Business keywords: pharmaceutical SMEs, biotech companies, electronic quality management system, GxP compliance, cloud hosting, quality management, audit management, inspection readiness, GMP, GCP, pre-validated systems, distributed teams, document management, pharma compliance, eQMS

Services & Products

Electronic Quality Management System (eQMS)
Training Hub
Audit and Inspection Management
Document Management
Digital Signatures
Cloud Storage
AI-Powered Process Automation

Target Customers

Pharmaceutical Start-Ups Pharmaceutical Scale-Ups Contract Research Organisations Pharmaceutical Service Providers

No funding data available for Docuply yet.

Docuply Alternatives & Competitors

View All Alternatives
Docuply vs
Eupry
Eupry Denmark

Gain full control of your temperature compliance at all times. No gaps, no mess.

Series A
66 employees
Biopharma, Biotechnology
Docuply vs
M-Files
M-Files United States

The Smarter Way to Work.

Growth
743 employees
Analytics, Automation
Docuply vs
C3 | Clinical Consulting Consortium
C3 | Clinical Consulting Consortium United States

C3 is a woman-owned niche CRO with an extensive network of highly experienced CRAs in various therap...

3 employees
Analytics, Health Care
View all alternatives

FAQ About Docuply

The electronic quality management system with fully integrated eTMF – for clinical biotech companies.
Docuply was founded in 2022.
Docuply is headquartered in Mannheim, Germany.
Docuply operates in Analytics, Biopharma, Pharmaceutical and SaaS. Its work centres on pharmaceutical SMEs, biotech companies, electronic quality management system and GxP compliance. Its customers include Pharmaceutical Start-Ups, Pharmaceutical Scale-Ups and Contract Research Organisations.
Docuply has a SaaS, B2B and Platform business model. Its revenue comes from Freemium, Subscription and Tiered Pricing.
Docuply has approximately 7 employees.
Docuply offers: Electronic Quality Management System (eQMS), Training Hub, Audit and Inspection Management, Document Management, Digital Signatures, Cloud Storage, AI-Powered Process Automation.
Top alternatives and competitors to Docuply include Eupry, M-Files, C3 | Clinical Consulting Consortium, Portcast, Vital Records Control (VRC). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Docuply and Eupry are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Docuply, https://bouncewatch.com/company/docuply, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout